Gene Query: VARS

Dataset Description Geneva Score
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 79.95
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 70.26
Genome wide expression change by RNF168 knocking down in MCF-7 cells 47.99
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 47.78
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 47.78
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 41.97
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 36.48
Genome wide expression change by RNF168 knocking down in NEC cells 35.72
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 35.47
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 35.47
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 35.38
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 33.25
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 33.22
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 33.2
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 32.57
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 32.57
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 28.61
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 28.22
Hijacking of stress response machinery by oncogenes in acute leukaemia 28.22
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 27.99
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 27.73
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 27.72
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 26.98
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 26.67
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 26.67
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 26.48
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 25.81
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 25.75
Differential analysis of gene regulation at transcript resolution by RNA-Seq 25.75
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 25.14
ETV7 and interferon response 25.14
Total RNA-seq in ALL-SIL upon JQ1 inhibition 24.94
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 24.69
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 24.35
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 24.27
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 23.96
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 23.95
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 23.95
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 23.8
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 22.74
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 21.85
DART-seq: an antibody-free method for global m6A detection 21.75
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 21.71
Endothelial gene expression analysis 21.71
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 21.61
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 21.61
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 21.4
RNA transcriptome analysis during HSV-1 infection 21.08
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 20.33
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 20.33
MOF acetyl transferase regulates transcription and respiration in mitochondria 20.31
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 19.83
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 19.69
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 19.45
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 19.45
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 19.3
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 19.3
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 19.25
RNA-seq of resting and activated CD4+ T cells +-JQ1 19.09
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 18.96
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 18.91
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 18.78
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 18.78
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 18.69
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 18.64
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 18.64
Genome-wide functional assessment of enhancer activities in the human genome 18.0
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 17.9
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 17.52
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 17.42
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 17.4
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 17.23
Expression level comparison under dividing and quiescent states in human primary fibroblasts 17.18
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 17.14
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 17.11
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 17.07
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 17.06
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 17.06
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 16.81
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 16.57
RNA-seq analysis of differentiating human erythroblasts 16.52
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 16.44
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 16.39
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 16.38
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 16.35
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 16.01
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 15.87
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 15.76
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 15.69
Sensing self and nonself circular RNAs 15.65
Rorc disruption in human FG pancreatic cancer cells 15.63
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 15.63
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 15.55
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 15.42
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 15.26
RNA sequencing of primary human platelets and in vitro cell lines 15.13
RNA-sequencing of formalin fixed human primary melanoma tissue 15.12
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 15.11
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 15.11
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 14.95
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 14.93
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 14.8
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 14.77
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 14.73
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 14.66
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 14.62
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 14.62
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 14.59
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 14.57
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 14.52
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 14.45
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 14.39
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 14.3
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 14.23
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 14.2
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 14.19
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 14.19
Role of XRN2 ribonucleolytic activity in RNA metabolism 14.14
A549 cells and MSR-A549 cells 13.97
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 13.97
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 13.93
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 13.87
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 13.69
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 13.58
Selective expression of long non-coding RNAs in a breast cancer cell progression model 13.52
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 13.4
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 13.31
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 13.31
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 13.17
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 13.17
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 13.15
Identification of HOXB13 target genes responsive to BET inhibitors 13.08
TGF-β regulation of miRNA expression in pancreatic cancer 13.05
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 13.04
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 13.01
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 12.98
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 12.94
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 12.85
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 12.82
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 12.73
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 12.71
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 12.67
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 12.67
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 12.66
IDH3a KO RNA-seq 12.66
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 12.61
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 12.61
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 12.56
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 12.56
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 12.54
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 12.5
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 12.49
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 12.49
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 12.23
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 12.23
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 12.17
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 12.13
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 12.13
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 12.11
The pause-initiation limit restricts transcription activation in human cells 12.05
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 12.04
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 12.02
RNA-seq of tumor cells following angiopellosis extravasation 11.99
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 11.97
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 11.96
U1 snRNP telescripting regulates size-function stratified human genome 11.96
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 11.94
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 11.94
Effect of mitochondria deficiency on senescence-associated gene expression 11.9
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 11.89
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 11.79
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 11.7
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 11.67
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 11.66
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 11.65
PNET animal model: new insights (II) 11.63
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 11.59
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 11.57
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 11.54
11.5
Effect of Influenza virus infection on lncRNA expression in A549 cells 11.46
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 11.4
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 11.4
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 11.14
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 11.13
Expression and functions of long noncoding RNAs during human T helper cell differentiation 10.97
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 10.96
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 10.96
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 10.92
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 10.9
Targeting EZH2 in MYCN-amplified Neuroblastoma 10.89
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 10.89
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 10.88
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 10.87
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 10.69
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 10.67
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 10.62
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 10.59
Uridylation by TUT4 and TUT7 marks mRNA for degradation 10.53
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 10.5
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 10.47
The landscape of alternative splicing in aggressive prostate cancers 10.46
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 10.42
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 10.39
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 10.37
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 10.37
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 10.34
HNF1A deficiency impairs β-cell fate, granule maturation and function 10.31
NRDE2 negatively regulates nuclear exosome functions 10.27
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 10.2
Landscape and variation of RNA secondary structure across the human transcriptome 10.18
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 10.12
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 10.11
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 10.11
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 10.09
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 10.08
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 10.06
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 9.98
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 9.94
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 9.92
Differentiation enhances Zika virus infection in neuronal brain cells 9.91
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 9.86
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 9.85
The interplay between SOX4 and SMAD3 in the context of breast cancer 9.81
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 9.81
Studying the selectivity of a small molecule Synucleozid on transcriptome 9.81
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 9.78
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 9.73
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 9.7
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 9.7
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 9.69
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 9.66
RNA sequencing of BT142 and TS603 cell lines 9.66
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 9.66
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 9.65
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 9.64
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 9.62
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 9.62
RNA Sequencing of three pairs of gastric cancer 9.59
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 9.56
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 9.46
Differentially expressed vascular development genes for iPSC-ECs from CDI 9.44
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 9.43
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 9.43
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 9.42
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 9.37
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 9.36
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 9.36
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 9.34
MCF-7 as a model for functional analysis of breast cancer risk variants 9.29
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 9.27
Lysine benzoylation is a novel histone mark [RNA-seq] 9.25
Lysine benzoylation is a novel histone mark 9.25
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 9.25
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 9.23
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 9.23
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 9.18
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 9.16
High-throughput sequencing of pluripotent cells 9.14
RNA seq with AML (NB4) cells upon FTO inhibition 9.14
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 9.14
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 9.14
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 9.11
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 9.11
RNA-seq of YB5 cells treated with Proscillaridin A 9.07
RNA m5C Methylation in breast cancer using MeRIP-Seq 9.07
Global transcriptome analysis of HAP1 cells 9.05
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 9.04
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 9.04
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 9.02
Hepatitis C virus functionally sequesters miR-122 9.02
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 8.98
Aneuploidy-induced cellular stresses limit autophagic degradation. 8.95
SLAM-seq for K562 endogenous mRNA decay 8.91
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 8.89
AR-independent prostate cancer is sustained through FGF signaling 8.88
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 8.83
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 8.67
Conservative alteration of chromosomal expression pattern across human solid tumor types 8.59
BACH2 in human plasma cell fate decision 8.56
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 8.54
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 8.46
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 8.46
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 8.45
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 8.35
RNA-sequencing in irradiated and normal A549 cells. 8.33
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 8.32
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 8.32
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 8.31
SRSF1 role in cellular gene expression and splicing 8.31
TT-Seq captures the human transient transcriptome 8.25
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 8.22
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 8.17
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 8.17
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 8.15
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 8.14
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 7.97
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 7.97
Oncogenic MYC induces a dependency on the spliceosome in human cancer 7.96
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 7.95
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 7.92
TAF1 is critical for AE driven leukemogenesis 7.92
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 7.91
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 7.79
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 7.73
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 7.61
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 7.6
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 7.6
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 7.56
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 7.52
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 7.44
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 7.42
Co-regulation of splicing by Rbfox1 and hnRNP M 7.38
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 7.38
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 7.33
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 7.33
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 7.27
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 7.25
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 7.2
Regulation of poly(A) tail and translation during the somatic cell cycle 7.19
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 7.11
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 7.07
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 7.01
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 7.0
Global analyses of the effect of different cellular contexts on microRNA targeting 7.0
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 7.0
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 6.93
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 6.93
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 6.91
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 6.88
Recovery and analysis of nascent RNA 6.88
Primary Human B-cell Temporal Response to CD40L Stimulation 6.78
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 6.75
An integrative analysis of non-coding regulatory DNA variations associated with autism 6.67
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 6.64
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 6.64
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 6.53
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 6.53
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 6.53
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 6.53
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 6.52
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 6.51
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 6.45
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 6.45
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 6.41
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 6.41
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 6.31
A map of gene expression in neutrophil-like cell lines 6.24
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 6.18
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 6.11
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 5.91
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 5.9
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 5.9
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 5.9
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 5.81
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 5.78
miR-93 Targets in Human Endothelial Cells 5.7
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 5.66
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 5.59
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 5.58
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 5.55
Differential responses of human fetal brain neural stem cells to Zika virus infection 5.53
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 5.4
Finding missing proteins from epigenetically manipulated human cells 5.37
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 5.31
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 5.31
Transcriptome analysis upon C6orf203 silencing 5.24
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 5.19
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 5.15
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 5.15
mRNA differential expression analysis in a human ex vivo model of chronic wounds 4.99
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 4.98
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 4.94
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 4.92
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 4.9
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 4.84
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 4.8
Impact on erythroid progenitor type on erythroid differntiation 4.63
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 4.56
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 4.53
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 4.53
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 4.42
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 4.36
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 4.34
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 4.29
The DPYSL2 gene connects mTOR and schizophrenia 4.26
MYCi975 regulates MYC target genes 4.24
Triple vectors expand AAV transfer capacity in the retina 4.19
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 4.17
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 4.16
Tracking distinct RNA populations using efficient and reversible covalent chemistry 4.07
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 3.98
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 3.92
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 3.92
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 3.87
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 3.84
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 3.78
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 3.78
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 3.78
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 3.78
Clinker: visualizing fusion genes detected in RNA-seq data 3.66
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.64
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.64
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.53
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 3.47
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 3.47
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 3.44
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 3.44
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 3.42
ADAR1-editing of cellular and measles virus-derived duplex RNA 3.42
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 3.27
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 3.19
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 3.18
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 3.18
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 3.17
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 3.15
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 3.02
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 3.02
Global response to chemotherapy-induced apoptosis 3.0
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 2.98
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 2.98
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 2.97
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 2.97
SOX11 knockdown in B-ALL cell lines 2.94
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 2.83
Gene expression changes due to PARP knockdown in human cells 2.77
The pioneer factor CEBPA modulates vitamin D signaling 2.67
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 2.67
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 2.53
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 2.46
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 2.43
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 2.37
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 2.37
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 2.35
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 2.34
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 2.29
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.28
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.23
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 2.09
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.03
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 1.9
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.81
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 1.75
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 1.75
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.68
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.68
Determining mRNA half-lives on a transcriptome-wide scale 1.68
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 1.65
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 1.64
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 1.62
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 1.62
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.61
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 1.6
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 1.56
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.54
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 1.5
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 1.47
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 1.44
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.41
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.39
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.39
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 1.28
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.14
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 1.09
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 1.08
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.02
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.0
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.0
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 0.97
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 0.97
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.93
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 0.88
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 0.75
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 0.72
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.71
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.71
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.66
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.65
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.63
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.6
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.6
MRTF activates TEAD-YAP target gene expression 0.54
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.51
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.5
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.49
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.35
Transcriptomic analysis of human macrophages in 3D 0.34
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.3
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.28
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.28
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 0.23
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.22
BET bromodomain inhibition 0.21
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 0.21
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.17
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.06
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.06
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.06
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.04
Total RNA-seq in ALL-SIL upon TLX1 knockdown 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation